Seismic Therapeutic
William Marks has had a diverse work experience, beginning in 2008 when they were the President Emeritus and Statistician of the Harvard College Engineering Society. In 2009, they were the Finance Chair and Executive Board Member of the Harvard College Entrepreneurship Forum. In 2010, they were the Chief Financial Officer of KeenLean. In 2011, they were a Researcher at the Harvard Bioinnovation Laboratory and a Research Assistant at the Vecitis Lab. From 2013 to 2014, they were an Associate at the School of Engineering and Applied Sciences, Harvard University, and the United States-India Educational Foundation (USIEF), New Delhi. In 2020, they were a Senior Associate at Polaris Partners. Currently, they are a Strategy & Operations professional at Seismic Therapeutic.
William Marks has an extensive educational background. William obtained their Doctor of Philosophy - PhD from the University of Cambridge in the Department of Medicine. Prior to that, they attended Peddie School. William also holds a Bachelor of Science - BS and Master of Science - MS from Harvard University in Bioengineering and Biomedical Engineering.
This person is not in the org chart
This person is not in any offices
Seismic Therapeutic
1 followers
Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.